NOVOS - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    210 followers

  • Elon Musk

    Elon Musk

    80 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    58 followers

  • Jack Dorsey

    Jack Dorsey

    40 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    212 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
NOVOS

NOVOS

Publication
0 followers

Science-backed longevity education from an independent nutraceutical team and scientific advisors.

What a Peer-Reviewed Study Found About NOVOS Core and Skin Aging Support
News•Apr 7, 2026

What a Peer-Reviewed Study Found About NOVOS Core and Skin Aging Support

A 2024 peer‑reviewed study in *Nutrients* used a 3‑dimensional human keratinocyte model to test a NOVOS formulation containing the NOVOS Core blend. The research showed that a 24‑hour treatment did not cause DNA damage and significantly lowered oxidative‑stress and DNA‑damage markers when cells were later exposed to a genotoxic agent. The multi‑ingredient formula performed better at lower concentrations than simpler comparators, suggesting synergistic action. These results provide pre‑clinical evidence that NOVOS Core may bolster cellular resilience linked to skin‑aging biology.

By NOVOS